If you are interested in participating in a Duke Vaccine and Trials Unit study, please contact us to receive notices about current and future research studies.
Email: dvtustudies@duke.edu | Telephone: 919-971-5649
Active Clinical Trials
Dr. Smith is leading a study to assess the safety, tolerability, and immunogenicity of a multivalent pneumococcal conjugate vaccine in infants. Further information about this study can be found at clinicaltrials.gov. The NCT number is NCT007629440.
Dr. Walter is leading a study to learn about a Clostridioides difficile vaccine in people 65 years of age and older. Further information about this study can be found at clinicaltrials.gov. The NCT number is NCT07282665.
Dr. Woods is leading a controlled human infection model study to determine the optimal dose of a pH1N1 influenza virus. Further information about this study can be found at clinicaltrials.gov. The NCT number is NCT07110532.
Dr. Smith is leading a study to assess the safety of RSV prevenetive monoclonal antibody when administered with routine childhood immunization. Further information about this study can be found at clinicaltrials.gov. The NCT number is NCT007158814.
Dr. Wolfe is leading a study to learn about revaccination with an RSV vaccine in immunocompromised adults. Further information about this study can be found at clinicaltrials.gov. The NCT number is NCT07768345.
Dr. Smith is leading a study to learn about the natural history of Epstein-Barr virus infection.